Organogenesis Holdings (ORGO) Prepaid Assets (2016 - 2026)
Organogenesis Holdings' (ORGO) quarterly Prepaid Assets came in at $28.6 million in Q1 2026, up 59.71% year-on-year from $17.9 million in Q1 2025, and up 56.06% quarter-over-quarter from $18.4 million in Q4 2025.
Organogenesis Holdings (ORGO) Prepaid Assets (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Prepaid Assets history runs 11 years deep, the most recent figure standing at $28.6 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 59.71% year-over-year to $28.6 million in Q1 2026; TTM through Mar 2026 was $28.6 million, a 59.71% increase from a year earlier, with the FY2025 full-year figure at $18.4 million, up 33.87% from the prior year.
- Prepaid Assets grew to $28.6 million in Q1 2026 per ORGO's latest filing, from $18.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $28.6 million in Q1 2026 and bottomed at $4.7 million in Q3 2022.
- The 5-year median for Prepaid Assets is $10.9 million (2024), against an average of $13.6 million.
- Across the five-year window, Prepaid Assets declined 6.48% in 2022 and soared 155.09% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $5.1 million in 2022, then surged by 105.54% to $10.5 million in 2023, then jumped by 31.15% to $13.7 million in 2024, then surged by 33.87% to $18.4 million in 2025, then surged by 56.06% to $28.6 million in 2026.
- Per Business Quant, the three latest ORGO Prepaid Assets figures stand at $28.6 million (Q1 2026), $18.4 million (Q4 2025), and $22.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.64 Mn |
| Dec 31, 2025 | 18.35 Mn |
| Sep 30, 2025 | 22.65 Mn |
| Jun 30, 2025 | 27.78 Mn |
| Mar 31, 2025 | 17.94 Mn |
| Dec 31, 2024 | 13.71 Mn |
| Sep 30, 2024 | 15.28 Mn |
| Jun 30, 2024 | 10.89 Mn |
| Mar 31, 2024 | 13.98 Mn |
| Dec 31, 2023 | 10.45 Mn |
| Sep 30, 2023 | 9.57 Mn |
| Jun 30, 2023 | 7.95 Mn |
| Mar 31, 2023 | 9.85 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Sep 30, 2022 | 4.71 Mn |
| Jun 30, 2022 | 6.54 Mn |
| Mar 31, 2022 | 7.14 Mn |
| Dec 31, 2021 | 4.97 Mn |
| Sep 30, 2021 | 5.03 Mn |
| Jun 30, 2021 | 6.58 Mn |